Chinese Biotech Gains Ground as Morgan Stanley Forecasts Surge in FDA Approvals

By Meghana Keshavan · STAT News · 2026-10-01

Chinese Biotech Gains Ground as Morgan Stanley Forecasts Surge in FDA Approvals

According to STAT News, the pharmaceutical landscape is shifting as Chinese firms now manage nearly half of the global drug pipeline. Industry leaders recently gathered in Shanghai to discuss how these companies are accelerating development timelines while significantly reducing

According to STAT News, the pharmaceutical landscape is shifting as Chinese firms now manage nearly half of the global drug pipeline. Industry leaders recently gathered in Shanghai to discuss how these companies are accelerating development timelines while significantly reducing